Comment on "The pros and cons of continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin". Authors' reply

Endocrine. 2018 Apr;60(1):197. doi: 10.1007/s12020-018-1527-2. Epub 2018 Feb 5.

Authors

Michela Petrizzo¹, Maria Ida Maiorino², Katherine Esposito¹

Affiliations

¹ Diabetes Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.
² Diabetes Unit, University of Campania "Luigi Vanvitelli", Naples, Italy. mariaida.maiorino@unicampania.it.

PMID: 29404902
DOI: 10.1007/s12020-018-1527-2

No abstract available

Publication types

Letter
Comment

MeSH terms

Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1*
Glucose
Glycated Hemoglobin / analysis
Humans
Hypoglycemia
Hypoglycemic Agents
Injections, Subcutaneous
Insulin Infusion Systems
Insulin*

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
Insulin
Glucose